Trial Profile
Long‐term evaluation of 24 hour ambulatory blood pressure monitoring in patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension treated with droxidopa
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Droxidopa (Primary)
- Indications Parkinson's disease
- Focus Pharmacodynamics
- 20 Aug 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.